The Paula Takacs Foundation For Sa… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2010

Legal Domicile

Phone

7047790232

Tax Period

2025-01-01 to 2025-12-31

The Paula Takacs Foundation For Sarcoma Research, founded in 2010, is a small nonprofit in the Medical Research sector that reported $676K in total revenue in fiscal year 2025. Revenue grew 8% year-over-year, indicating healthy expansion. The organization ran a surplus of $114K, a strong 17% operating margin.

Mission

The mission is to raise funds for local research, amplify awareness, and accelerate the fight to end sarcoma cancers - resulting in local and global development pathway for new sarcoma treatments and increase the speed of accurate diagnoses.

Program Service Accomplishments

Program 1

Expenses: $532,174 Revenue: $608,661

THE PAUL TAKACS FOUNDATION FOR SARCOMA RESEARCH, A 501c(3) TAX EXEMPT ORGANIZATION RAISES BOTH AWARENESS AND CRITICAL FUNDING FOR SARCOMA RESEARCH. SARCOMAS CURRENTLY REPRESENTS APPROXIMATELY 1% OF ADULT AND 15% OF CHILDHOOD CANCERS, AND THEREFORE LACK THE LEVEL OF GOVERNMENT FUNDING THAT OTHER MORE PREVALENT CANCERS OFTEN RECEIVE. IN ADDITION, THERE ARE 70 DIFFERENT TYPES OF SARCOMAS, ALL OF WHICH RESPOND DIFFERENTLY TO TREATMENT. WITH THESE STATISTICS, COUPLED WITH THE RESISTANCE THAT MANY SARCOMA TYPES DISPLAY TO TRADITIONAL CANCER TREATMENTS, THERE IS A PRESSING NEED FOR PRIVATE FUNDING TO SUPPORT THE EFFORT TOWARD MORE EFFECTIVE TREATMENTS FOR SARCOMAS.

Program 2

Expenses: $10,360 Revenue: $58,000

Day One Program offers patient resources and comfort kits to newly diagnosed sarcoma patients and families.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2025)

Revenue Breakdown

Contributions & Grants $666,662

Program Service Revenue $0

Investment Income $8,851

Other Revenue $0

TOTAL REVENUE $675,513

Expense Breakdown

Grants Paid $285,000

Salaries & Benefits $149,578

Fundraising Expenses $4,466

Program Expenses $542,534

Other Expenses $126,835

TOTAL EXPENSES $561,413

Year-over-Year Comparison

	2025	2024	Change
Revenue	$675,513	$624,980	+0.1%
Expenses	$561,413	$568,454	0.0%
Net Income	$114,100	$56,526	+1.0%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$85,707

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Christine Wade	Executive Director - 2024	40.00	Officer	$85,707	$0	$85,707
Maya Logan	Director	5.00	Director	$0	$0	$0
Amber Powderly	Director	5.00	Director	$0	$0	$0
Suzanne Levine	Vice President	5.00	Officer Director	$0	$0	$0
Andrew Sanctis	Director	5.00	Director	$0	$0	$0
Charlie Bartz	Director	5.00	Director	$0	$0	$0
Lee Sugg	Treasurer	10.00	Officer Director	$0	$0	$0
Heather Lopane	Secretary	5.00	Officer Director	$0	$0	$0
Thomas Valle	Director	5.00	Director	$0	$0	$0
Elizabeth Romano	Director	5.00	Director	$0	$0	$0
Heather Franklin	Director	5.00	Director	$0	$0	$0
Christopher Harris	Director	5.00	Director	$0	$0	$0
Doug Sleeper	President	2.00	Officer Director	$0	$0	$0
Johann Hsu	Director	5.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$675,513	$561,413	$906,963	$114,100
2024	$624,980	$568,454	$1,117,863	$56,526
2023	$578,647	$440,029	$718,099	$138,618
2022	$617,474	$391,068	$577,201	$226,406
2022	$617,474	$391,068	$577,201	$226,406
2021	$369,393	$327,903	$350,643	$41,490
2021	$369,393	$327,903	$350,643	$41,490
2020	$459,186	$326,414	$313,398	$132,772
2019	$384,989	$354,107	$176,986	$30,882
2018	$310,606	$339,101	$146,313	$-28,495

The Paula Takacs Foundation For Sarcoma Research